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Abstract
Background—Screening for IPV in health care settings might increase women's knowledge or 
awareness around its frequency and its impact on health. When IPV is disclosed, assuring women 
it is not their fault should improve their knowledge that IPV is the perpetrator's responsibility. 
Providing information about IPV resources may also increase women's knowledge about the 
availability of solutions.
Methods—Women (n=2708) were randomly assigned to one of three groups: (1) partner 
violence screen plus video referral and list of local partner violence resources if screening was 
positive (n=909); (2) partner violence resource list only without screen (n=893); and (3) a no-
screen, no-partner violence resource list control group (n=898). One year later, 2364 women 
(87%) were re-contacted and asked questions assessing their knowledge of the frequency of 
partner violence, its impact on physical and mental health, the availability of resources to help 
women experiencing partner violence, and that it is the perpetrator's fault.
Results—There were no differences between women screened and provided with a partner 
violence resource list compared to a control group as to women's knowledge of the frequency of 
IPV, its impact on physical or mental health, or the availability of IPV services in their 
community. However, among women who experienced IPV in the year before or year after 
enrolling in the trial, those who were provided a list of IPV resources without screening were 
significantly less likely to know that IPV is not the victim's fault than those in the control or list 
plus screening conditions.
Conclusions—The results of this study suggest that providing information on partner violence 
resources, with or without asking questions about partner violence, did not result in improved 
knowledge.
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Introduction
Although screening women for intimate partner violence (IPV) with provision of IPV 
resource information may not have an impact on women’s overall health or recurrence of 
IPV [1,2], it has shown positive impact on reproductive coercion (e.g., birth control 
sabotage, pressure to get pregnant) [3], preterm births and newborns with very low birth 
weight [4], substantiated reports of child maltreatment [5], and mothers’ self-reported 
psychological and physical aggression toward children [6]. Screening may also increase 
detection of IPV, discussion about it with health care providers [7,8], and referrals to IPV 
services [9,10]. In addition, a small cross-sectional survey suggests screening and referral 
may also increase women’s awareness of the frequency of IPV, its impact on health, the 
resources available, and that the perpetrator is the responsible party [11]. Experimental 
research of screening and referral with a larger sample might help confirm these findings.
Screening or routine inquiry for IPV in health care settings might increase women’s 
knowledge or awareness about IPV in at least two ways. Routine questions about IPV, 
especially if prefaced by comments referring to its frequency, might lead women to perceive 
IPV to be a common condition for women. In addition, when asked in a health care setting, 
women might also make the connection between IPV and poor health [12]. When IPV is 
disclosed, assuring women it is not their fault should improve acknowledgement of 
perpetrators’ responsibility for IPV. Providing information about IPV resources could also 
increase women’s knowledge about the availability of solutions.
Information about IPV could be provided to all women without screening [13]. This 
approach would probably be less costly to implement compared to screening and referral 
and may be more respectful of women’s autonomy in making use of existing IPV services. 
However, whether this approach increases women’s awareness of available IPV resources 
(e.g., women may not be able to or want to read the information) or have other effects on 
women’s knowledge around IPV needs to be determined.
Answers to these questions are important because according to the transtheoretical model of 
health behavior change [14], knowing the impact of a problem on health and the options 
available may help individuals move towards contemplating change and taking action. A 
recent qualitative study suggests this type of knowledge may contribute to contemplating 
action among women exposed to IPV [15].
This paper reports secondary analyses using data collected in a randomized controlled trial 
(RCT). These analyses examine whether: (1) screening (plus information about IPV 
resources if positive) is equal to or better than providing all women IPV resource 
information without screening; and (2) whether either intervention is better than usual care 
in terms of women’s knowledge of the prevalence of IPV, IPV’s impact on health, or 
available IPV resources. Because information about IPV may impact women differentially 
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according to their experiences with IPV, these outcomes are examined among four 
subgroups: women experiencing any IPV in their lifetime, women experiencing IPV in the 
year previous to enrollment, women experiencing IPV in the year after enrollment, and 
women who have never experienced IPV.
Methods
The data for this study come from a three-arm RCT conducted in ten primary health care 
clinics (eight public and two private) in Chicago to establish the impact of screening and 
referral on women’s health (see [1] for a complete description of the original study). 
Participants in this RCT were limited to adult, English or Spanish speaking women seeking 
clinical services at these clinics, with access to a telephone, and willing to share contact 
information for at least one reliable phone number for follow-up. Women were excluded 
from participation if they were accompanied by their partner and could not be safely 
separated at the clinical enrollment site, accompanied by a child over 3 years of age without 
alternative adequate provision for child care, or visually, hearing or mentally impaired. 
Women were recruited from May 2009 thru April 2010 and assessed at enrollment and again 
one year later.
Randomization process and description of study groups
The randomization procedure was built into the computer system along with the audio-
computer-assisted self-interview (A-CASI) program; the automated randomization 
procedure occurred after the participant had given her consent and was entered into the 
system. Participants were randomized to one of three groups using blocks of 30 (i.e., 10 per 
block) and stratified by clinical site, with allocation concealed from participants and 
research assistants. The groups were:
1. A “screen-plus-resource-list” group in which women were screened by an Audio-
Computer-Assisted-Self-interview (ACASI) using the three-item Partner Violence 
Screen (PVS) instrument [16]. The PVS assesses the presence of physical IPV in 
the past year (hit, kicked, punched or otherwise hurt) and women’s perception of 
being ‘safe’ in her current relationship or a partner from a previous relationship 
making her feel unsafe. In the introduction to the three screening questions, women 
were told “Violence is a problem for many women. Because it affects their health, 
we are asking our patients about it”. Women screening positive were shown a brief 
video on the computer screen in which an IPV advocate mentioned that one in four 
women will experience IPV during their lifetime, that IPV harms women’s health 
and gave both physical and mental health examples of this harm; emphasized that 
IPV was not her fault; informed her that help such as the local hospital-based IPV 
advocacy program was available, telephone numbers of several IPV services would 
be on the printout she would receive after the video, and encouraged the viewer to 
seek help. After the video, IPV positive women received a computer printout of 
contact information for the local IPV advocacy program, the local and national 24-
hour IPV hot lines, local battered women shelters, and the local battered women’s 
outreach program. For safety reasons, the IPV resources were combined with a list 
of general resources (i.e., health services, legal aid, parenting support, general 
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counseling services, alcohol and drug treatment, and shelters for the homeless). If 
screening negative, women received the list of general resources only. 
Computerized screening and referral was selected as the preferred method based on 
a pilot study showing higher rates of IPV disclosure and similar rates of use of 
referral resources compared to health care provider screening and referral [17].
2. A “resource-list-only” group in which all women were given the same computer 
printout as those screening positive in the “screenplus-resource-list” group without 
screening.
3. A “control” group in which women were neither screened nor given the IPV 
resource list, but were given the list of general resources. Although not all of these 
resources have been rigorously evaluated, none of the resources on this general list 
have been shown to have positive or negative health impacts among women 
experiencing IPV [18].
Measures
The following five outcomes were assessed at the one-year follow-up telephone interview:
Knowledge of the prevalence of IPV was based on women’s answer to the question: “If 
there were 10 women from your neighborhood sitting in a room, how many of these women 
would you guess have ever been physically, verbally, emotionally, or sexually threatened or 
harmed by an intimate partner?”. The “correct” answer corresponded to the observed 
prevalence in this study (±1) specifically among study participants at the clinic where they 
were enrolled. As a result, the correct answer was between 4 and 6 for women enrolled at 8 
clinics, and between 3 and 5 or 5 and 7 for the remaining two. This question was previously 
used in a random digit dial survey [19].
Knowledge of the negative impact of IPV on health was based on women’s answer to the 
following two questions: (a) “Which woman is more likely to have problems with her 
physical health: a woman who has been threatened or harmed by an intimate partner or a 
woman who has not - or are both of them equally likely to have physical health problems?” 
and (b) “Which woman is more likely to have problems with mental health such as anxiety, 
depression or substance abuse: a woman who has been threatened or harmed by an intimate 
partner or a woman who has not - or are both of them equally likely to have mental health 
problems?”. Women responding that those who experience IPV are more likely to have 
problems with their physical and mental health were considered to have the correct 
knowledge.
Knowledge of availability of services for IPV: Women agreeing with the statement “Women 
who are hurt by their partners can get help if they need it” (Agree/Disagree) were considered 
to have this knowledge.
Knowledge of available services for women who experience IPV: Women were considered 
to know if they reported at least one local IPV agency in response to the question: “Where 
can a woman who is being hurt by an intimate partner get help in your community?”.
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Knowledge of responsibility for IPV: Women disagreeing with the statement “Women 
usually get hurt by their partners because of something the women did” (Agree/Disagree) 
were considered to have this knowledge.
Questions for outcomes two through five were developed specifically for this study. The 
study team reviewed several iterations of these questions until consensus was reached as to 
their face validity. They were subsequently tested among two English speakers and nine 
Spanish speakers and revised again to improve comprehension.
Demographic information, collected to establish the comparability of the study groups, was 
based on participants’ self-reported age, highest level of education completed, insurance 
status, and racialethnic group.
Women’s subgroup status according to their experience with IPV was determined by 
women’s responses at the one-year follow-up interview to 18 questions adapted from the 
National Violence Against Women Survey [20]. Three questions asked about psychological 
abuse (e.g., called you names or belittled you”), four asked about partners’ controlling 
behaviors (e.g., “tried to limit your contact with friends or family”), eight asked about 
partners’ physical aggression without a weapon (e.g., “pushed, grabbed, or shoved you”), 
two asked about being threatened or assaulted by a partner with a weapon (e.g., used or 
threatened you with a knife”), and one asked about sexual abuse by a partner (i.e., “made 
you or tried to make you have vaginal, oral or anal sex”). Positive endorsement of any 
question was considered “experienced any IPV” and negative responses to all questions 
were considered “never experienced IPV”. Women reporting any IPV were then asked if 
any of these experiences had occurred in the past year (if “yes”, they were categorized as 
“experiencing IPV after enrollment”) and also asked if any of these experiences had 
occurred in the year prior to enrolling in the study.
Procedures
Trained bilingual research assistants (RAs) approached potential participants in each clinic’s 
waiting room to determine their interest and eligibility and obtain written consent from those 
eligible. RAs then accompanied participants to private rooms or kiosks equipped with touch-
screen computers and headphones and started the ACASI. Interviews lasted an average of 20 
minutes. Interviews and resources were available in both English and Spanish. After 
completion of the ACASI, the RA negotiated safe follow-up contact times and telephone 
numbers, a safe message to leave on an answering machine or if someone else answered, a 
code word the participant could use if interrupted during the follow-up interview and an 
address to send a reminder letter and a money order. Study participants were compensated 
$20 for the baseline interview and $15 for the follow-up interview.
A month before the one year follow-up Computer-Assisted Telephone Interview (CATI), the 
RA reminded participants of the upcoming interview, and updated their contact information 
using multiple techniques (i.e., mailed reminder letters, calls to women and their contacts, 
reviews of public access jail and death websites, and surveillance of the health care 
electronic appointment system). The research staff, blinded to study group assignment, 
conducted CATI follow-up interviews between 48 and 56 weeks following enrollment 
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during times negotiated with women at enrollment. On average, 8.8 attempts were made to 
locate women for the one year follow-up interview.
This study protocol was approved by the institutional review boards at the Centers for 
Disease Control and Prevention (CDC), the Cook County Hospital and Health Services, and 
Rush Medical University.
Statistical Analysis
Women were divided into four subgroups based on their responses to the questions on 
exposure to IPV: (1) women experiencing any IPV in their lifetime; (2) women experiencing 
IPV in the year previous to enrollment; (3) women experiencing IPV in the year after 
enrollment; and (4) women who had never experienced IPV. Descriptive statistics were used 
to compare demographic characteristics of participants across the three study groups and 
across the four IPV exposure subgroups as well as for each of the outcomes.
Logistic regression was used to test whether study condition interacted with exposure to 
IPV. Chi square tests (for categorical variables) or F ratios (for comparing means) were used 
to establish statistically significant differences between the four subgroups (based on 
experiences with IPV) and between the three randomly allocated study groups. Partitioned 
Chi Square [21] was used to compare pairwise differences. A sample size of 400 women in 
each group is required for a power of 80% to detect a difference of 10 percentage points 
with a two-tailed test at α=.05.
Results
Of 3537 women approached, 161 (5%) did not meet eligibility criteria, 668 (19%) were not 
interested in participating, and 2708 (77%) were enrolled and randomized to one of three 
study groups (complete numbers and reasons for exclusion or non-participation available in 
[1]. One year after enrollment, 2364 (87%) women completed the follow-up interview 
(88.1% in arm 1; 86.5% in arm 2; 88.1% in arm 3) with no statistically significant 
differences (p=.23) in the proportion lost to follow-up by study group. Women assessed at 
follow-up were on average 39 years old, predominantly African American (54%) or Latina 
(38%), with a high school education or less (56%), and uninsured (58%) with no significant 
differences between study groups (Table 1).
Women lost to follow-up were an average of five years younger (p<. 001), more likely to 
have public insurance (p<.001) and have less formal education (p=.02) than women who 
completed the follow-up interview. The demographic characteristics of the four subgroups 
of women categorized according to their experiences with IPV did not significantly differ 
from the overall enrolled sample nor were there any significant differences between the 
three randomly allocated study groups in any of the four subgroups (data not shown).
Table 2 presents the percent of women who knew the prevalence, consequences and 
availability of help stratified by whether they had been exposed to IPV at any time during 
their life, exposed in the year prior to enrollment, the year after enrollment or never exposed 
by the randomly allocated study groups.
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Overall, between 33% and 34% of women across the four IPV exposure subgroups knew the 
prevalence of IPV in their community; between 45% and 49% knew that IPV had adverse 
effects on physical health; between 63% and 67% knew IPV had adverse effects on mental 
health; between 94% and 96% knew help was available but only 16% to 17% were able to 
name at least one IPV agency in their community. Finally, between 82% and 86% of women 
knew IPV is not because of something a woman did (“not her fault”). None of the 
differences observed between the four subgroups of women according to their experiences 
with IPV were statistically significant.
The interaction between study arm and timing of exposure to IPV was statistically 
significant only for knowing IPV is not because of something the woman did (“not her 
fault”; p<.01). Specifically, among the subgroup of women experiencing IPV in the year 
prior to enrollment as well as the subgroup of women experiencing IPV in the year after 
enrollment there were statistically significant differences between the three randomly 
allocated study groups (see last column of Table 2). These differences were further explored 
using pair-wise analyses and partitioned Chi square. Among the subgroup of women 
experiencing IPV in the year prior to enrollment as well as the subgroup of women 
experiencing IPV in the year after enrollment, women receiving the resource list only were 
significantly less likely than the control group (p=.01 and p=.008 respectively) and the 
screened-plus-resource-list group (p=.002 and p < .001, respectively) to know that IPV is 
not because of something women did while the screened-plus-resource-list group was not 
significantly different from the control group.
Discussion
In this three-arm randomized controlled trial, there were no differences between women 
screened and provided with a IPV resource list compared to a control group as to women’s 
awareness of the frequency of IPV, its impact on physical or mental health, or the 
availability of IPV services in their community. However, among women who were victims 
of IPV in the year before or year after enrollment, those who were provided a list of IPV 
resources without screening were significantly less likely to know that IPV is not the 
victim’s fault than those in the control or list plus screening conditions.
Before discussing the implications of these findings, several limitations of the study must be 
acknowledged. A first set of limitations are potential sample biases. Although the 
participation rate was relatively high, we do not know if the 19% of nonparticipants differed 
from the participants. In addition, the 13% of those lost to follow-up were significantly 
younger, more likely to have public insurance, and have less formal education than women 
retained and may have differed in outcomes as well. However, because the proportion of 
those lost to follow-up was small and the demographic characteristics of the baseline sample 
did not differ from the sample retained, we would expect the impact of this attrition to have 
minimal effects on the estimates reported for each outcome. Furthermore, because there 
were no differences in loss to follow-up by allocation, the differences in outcomes by 
allocation should not be affected either. The findings may not generalize to other population 
groups as participants were limited to this urban setting, those with access to a telephone, 
African American or Latina, and less educated English or Spanish-speaking women.
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Recall bias may also be a problem for the categorization of the subgroups according to their 
experiences with IPV. This categorization was based on responses to questions on exposure 
to IPV at the one-year follow-up. Exposure to IPV was not assessed at baseline to avoid 
“contamination” (i.e., the control group receiving the intervention). It is possible that some 
women may not have remembered experiencing IPV two years earlier (i.e., the year prior to 
enrollment). Others may have mistaken the period of time when they actually experienced 
IPV. However, because the same question was used for all three study groups and there were 
no significant differences in the proportion reporting IPV in the year before or after 
enrolling in the study between the study groups, these potential errors in classification 
should not affect the findings.
Recall bias may also be a problem in our measure of “knowledge of local IPV resources”. 
The IPV list was provided a year earlier and women may not remember what was on the list. 
In addition, although the same measure was used across groups, recall may vary depending 
on the timing of exposure to IPV.
Measurement error is another potential limitation. Each of our measures of knowledge was 
based on one question. Although some of these items have been used previously [21], they 
have not been tested for validity or reliability. In addition, we did not establish or adjust for 
a baseline level of knowledge. However, given the lack of differences in demographic 
background or baseline scores for physical and mental health across allocation groups (see 
[1]), it appears that the randomization procedure worked well. Therefore we believe that 
differences in knowledge across groups at baseline were unlikely. Some questions (e.g., 
knowledge that help is available) may also have had a “ceiling effect” which makes 
differences between groups more difficult to detect. The results might be different among 
high risk women in communities where services were very limited, not well integrated, or 
new.
This trial had several important strengths such as random assignment, a no screen or 
resource list control group, small loss to follow-up, blinded assessment of outcomes, a mix 
of both public and private clinics, and a large number of Latina participants (who are often 
excluded from studies because of language barriers). These strengths far outweigh the 
limitations of this study.
There are few studies on the impact of interventions on women’s knowledge of IPV. 
Although Spangaro et al.’s [11] cross-sectional survey suggested that screening might 
increase women’s knowledge of IPV’s frequency, its impact on health, and the availability 
of IPV resources, our findings suggest otherwise. The current findings are consistent with 
another study suggesting coordinated community responses to IPV had no impact on 
knowledge of the frequency of IPV [19]. Perhaps other factors not measured in this study, 
such as knowing family or friends experiencing partner violence or exposure to partner 
violence campaigns, might have influenced participants’ knowledge.
Although possibly a statistical fluke given the multiple comparisons, the lower percentages 
of women who are currently experiencing IPV knowing that IPV is not because of 
something the woman did when provided a printed list of IPV resources without screening is 
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of concern. Runyan’s rationale [13] for proposing this type of intervention seemed 
reasonable and experiences of increased self-referral when information like this is provided 
[22] made this approach attractive. However, women who were screened and saw the video 
heard that IPV is not a woman’s fault; women only receiving the referral information did not 
hear this message. To better understand how referral only information may impact women 
and whether it is a safe practice, future studies might try to debrief participants to get their 
perceptions of this type of list.
Implications for Practice
The results of this study suggest that providing information on partner violence resources, 
with or without asking questions about partner violence did not result in improved 
knowledge. Additional research could increase our understanding of how women 
experiencing IPV interpret resource lists without screening, as has been suggested for states 
with mandatory reporting of IPV [23]. Moreover, as Morocco and Cole have suggested [24], 
research is needed to evaluate the effects of screening coupled with stronger interventions. 
In fact, trials showing positive impacts of screening plus stronger interventions such as a 30-
minute counseling session [25] to multiple counseling sessions [4] suggest this is a 
promising direction for future efforts.
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